The compression therapy market is expected to experience significant growth, increasing from USD 4.5 billion in 2025 to USD 5.9 billion by 2030, at a CAGR of 5.5%.
This expansion is driven by several factors, including a growing elderly population, a notable rise in chronic venous insufficiency cases, and an increase in lymphedema related to cancer treatments. Additionally, the prevalence of sedentary lifestyles and rising obesity rates has led to a surge in circulatory disorders, creating a higher demand for non-invasive treatment options.
Improvements in product comfort, the development of discreet wearable designs, and increased clinical awareness among physicians have further contributed to the adoption of compression therapy in outpatient and home settings. These trends, along with wider reimbursement coverage in key markets, continue to bolster global market growth.
“Compression garments dominated the market in 2024.”
Compression garments lead the compression therapy market due to their extensive use in treating conditions like varicose veins, lymphedema, and chronic venous insufficiency. These products, including stockings, sleeves, and wraps, are popular because they are easy to use, available in various compression levels, and suitable for clinical settings and home care. Their increasing importance in post-surgical recovery and preventive care for at-risk populations, such as the elderly and those with sedentary lifestyles, has further driven demand. Additionally, ongoing innovations in product design, including the use of more breathable and comfortable fabrics, support their continued dominance in the market.
“The hospitals & clinics segment held the largest share of the compression therapy market in 2024.”
Hospitals & clinics are the primary distribution channels in the compression therapy market, especially for specialty products such as pneumatic compression devices and advanced therapeutic stockings. These medical facilities play a crucial role in treating conditions like chronic venous insufficiency, lymphedema, and post-surgical recovery. The prescriptions and recommendations made by physicians in clinical settings are vital for driving demand for compression therapy products. The growing clinical acceptance and well-established benefits of compression therapy contribute to its widespread use in these environments. Consequently, hospitals & clinics stand out as the leading distribution channels.
“The Asia Pacific regional segment is expected to register the highest CAGR in the compression therapy market during the forecast period.”
The growth in this market is driven by several factors, including an aging population in Japan and China, where venous and lymphatic issues are becoming more prevalent. Additionally, rising healthcare awareness and improvements in medical infrastructure in emerging economies like India are contributing to the increased use of compression therapy. Economic growth in the region is also elevating disposable incomes, enabling more individuals to access and afford these therapeutic products. Together, these trends, along with a growing acceptance of preventive care and post-surgical treatment, are accelerating market growth in the Asia Pacific (APAC) region.
A breakdown of the primary participants referred to for this report is provided below:
• By Company: Tier 1 (35%), Tier 2 (45%), and Tier 3 (20%)
• By Designation: C-level Executives (35%), Director-level Executives (25%), and Others (40%)
• By Region: North America (40%), Europe (30%), Asia Pacific (20%), Latin America (5%), and the Middle East & Africa (5%)
Prominent players in the compression therapy market include 3M (US), BSN Medical (Germany), medi GmbH & Co. KG (Germany), Sigvaris AG (Switzerland), Juzo GmbH (Germany), Lohmann & Rauscher GmbH & Co. KG (Germany), DJO Global (US), JOBST (US), Therafirm (US), Bauerfeind AG (Germany), PAUL HARTMANN AG (Germany), CircAid Medical Products, Inc. (US), Tactile Medical (US), Bio Compression Systems, Inc. (US), THUASNE (France), among others.
Research Coverage
This market research analyzes the compression therapy market by segmenting it according to product, technique, application, distribution channel, and region. It provides insights into key factors influencing the market, including drivers, restraints, opportunities, and challenges. The report highlights opportunities and challenges for stakeholders and offers a detailed analysis of the competitive landscape, focusing on major market players. Additionally, it examines the micromarkets in greater detail, looking at growth patterns, opportunities, and their contributions to the overall compression therapy market. The report also includes revenue generation forecasts for various market segments and identifies growth opportunities across five key regions.
Key Benefits of Buying this Report
This report is valuable for both new and current players in the market, offering essential information to identify potential investment opportunities. It provides a comprehensive overview of both major and minor players, facilitating effective risk analysis and informed investment decisions. The report includes precise segmentation based on end users and geographical regions, offering detailed insights into niche market segments. Additionally, it highlights key trends, challenges, growth drivers, and opportunities, supporting strategic decision-making through a balanced analysis.
Through this report, readers get insightful views into the following parameters:
The compression therapy market is experiencing growth driven by several key factors, including the increasing prevalence of chronic conditions such as venous insufficiency and lymphedema, which require long-term management. Advances in automated diagnostic tools and smart compression devices are enhancing treatment efficiency and accuracy.
However, high product costs and a lack of awareness in emerging markets constrain this growth. However, there are also significant opportunities for the market, such as product innovation in areas like antimicrobials and custom-fit solutions. Market diversification through new product launches and expansions into untapped regions could further propel growth in the compression therapy market.
Product Development/Innovation: Emerging technologies, ongoing R&D activities, and recent launches of products in the market
Market Development: The report has elaborated the markets by segmenting the compression therapy market into different regions
Market Diversification: New product launches, unexploited markets, recent developments, and investments in the compression therapy market
Competitive Analysis: A comprehensive analysis of market share, product offerings, and leading strategies of major players, such as 3M (US), BSN Medical (Germany), medi GmbH & Co. KG (Germany), Sigvaris AG (Switzerland), Juzo GmbH (Germany), Lohmann & Rauscher GmbH & Co. KG (Germany), DJO Global (US), JOBST (US), Therafirm (US), Bauerfeind AG (Germany), PAUL HARTMANN AG (Germany), CircAid Medical Products, Inc. (US), Tactile Medical (US), Bio Compression Systems, Inc. (US), and THUASNE (France)
圖表清單 List of Tables & Figures
TABLE 1 STANDARD CURRENCY CONVERSION RATES 28
TABLE 2 PORTER’S FIVE FORCES ANALYSIS 60
TABLE 3 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 64
TABLE 4 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 64
TABLE 5 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 65
TABLE 6 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 65
TABLE 7 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 66
TABLE 8 REIMBURSEMENT CODES FOR VARIOUS PROCEDURES 66
TABLE 9 AVERAGE SELLING PRICE OF COMPRESSION STOCKINGS, BY KEY PLAYER,
2022–2024 (USD) 76
TABLE 10 AVERAGE SELLING PRICE OF COMPRESSION BRACES, BY KEY PLAYER,
2022–2024 (USD) 76
TABLE 11 AVERAGE SELLING PRICE OF COMPRESSION THERAPY PRODUCT TYPE, BY REGION, 2022–2024 77
TABLE 12 COMPRESSION THERAPY MARKET: LIST OF MAJOR PATENTS 80
TABLE 13 IMPORT DATA FOR HS CODE 611510, BY COUNTRY,
2020–2024 (USD THOUSAND) 81
TABLE 14 EXPORT DATA FOR HS CODE 611510, BY COUNTRY,
2020–2024 (USD THOUSAND) 82
TABLE 15 COMPRESSION THERAPY MARKET: KEY CONFERENCES & EVENTS, 2025–2026 82
TABLE 16 KEY REQUIREMENTS OF STAKEHOLDERS WHILE BUYING COMPRESSION
THERAPY PRODUCTS 84
TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF COMPRESSION
THERAPY PRODUCTS (%) 85
TABLE 18 UNMET CUSTOMER NEEDS & KEY PAIN POINTS 86
TABLE 19 US-ADJUSTED RECIPROCAL TARIFF RATES 88
TABLE 20 COMPRESSION THERAPY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 92
TABLE 21 COMPRESSION BANDAGES MARKET, BY REGION, 2023–2030 (USD MILLION) 93
TABLE 22 NORTH AMERICA: COMPRESSION BANDAGES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 93
TABLE 23 EUROPE: COMPRESSION BANDAGES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 94
TABLE 24 ASIA PACIFIC: COMPRESSION BANDAGES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 94
TABLE 25 LATIN AMERICA: COMPRESSION BANDAGES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 95
TABLE 26 MIDDLE EAST & AFRICA: COMPRESSION BANDAGES MARKET, BY REGION,
2023–2030 (USD MILLION) 95
TABLE 27 COMPRESSION BANDAGES MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 95
TABLE 28 COMPRESSION BANDAGES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 96
TABLE 29 COMPRESSION BANDAGES MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 96
TABLE 30 COMPRESSION WRAPS MARKET, BY REGION, 2023–2030 (USD MILLION) 97
TABLE 31 NORTH AMERICA: COMPRESSION WRAPS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 98
TABLE 32 EUROPE: COMPRESSION WRAPS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 98
TABLE 33 ASIA PACIFIC: COMPRESSION WRAPS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 99
TABLE 34 LATIN AMERICA: COMPRESSION WRAPS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 99
TABLE 35 MIDDLE EAST & AFRICA: COMPRESSION WRAPS MARKET, BY REGION,
2023–2030 (USD MILLION) 100
TABLE 36 COMPRESSION WRAPS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 100
TABLE 37 COMPRESSION WRAPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 101
TABLE 38 COMPRESSION WRAPS MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 101
TABLE 39 COMPRESSION STOCKINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 102
TABLE 40 COMPRESSION STOCKINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 103
TABLE 41 NORTH AMERICA: COMPRESSION STOCKINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 103
TABLE 42 EUROPE: COMPRESSION STOCKINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 104
TABLE 43 ASIA PACIFIC: COMPRESSION STOCKINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 104
TABLE 44 LATIN AMERICA: COMPRESSION STOCKINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 105
TABLE 45 MIDDLE EAST & AFRICA: COMPRESSION STOCKINGS MARKET, BY REGION,
2023–2030 (USD MILLION) 105
TABLE 46 COMPRESSION STOCKINGS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 105
TABLE 47 COMPRESSION STOCKINGS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 106
TABLE 48 COMPRESSION STOCKINGS MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 106
TABLE 49 CLASS I COMPRESSION STOCKINGS MARKET, BY REGION,
2023–2030 (USD MILLION) 107
TABLE 50 CLASS II COMPRESSION STOCKINGS MARKET, BY REGION,
2023–2030 (USD MILLION) 108
TABLE 51 CLASS III COMPRESSION STOCKINGS MARKET, BY REGION,
2023–2030 (USD MILLION) 109
TABLE 52 COMPRESSION TAPES MARKET, BY REGION, 2023–2030 (USD MILLION) 109
TABLE 53 NORTH AMERICA: COMPRESSION TAPES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 110
TABLE 54 EUROPE: COMPRESSION TAPES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 110
TABLE 55 ASIA PACIFIC: COMPRESSION TAPES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 111
TABLE 56 LATIN AMERICA: COMPRESSION TAPES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 111
TABLE 57 MIDDLE EAST & AFRICA: COMPRESSION TAPES MARKET, BY REGION,
2023–2030 (USD MILLION) 112
TABLE 58 COMPRESSION TAPES MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 112
TABLE 59 COMPRESSION TAPES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 113
TABLE 60 COMPRESSION TAPES MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 113
TABLE 61 PNEUMATIC COMPRESSION DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 115
TABLE 62 PNEUMATIC COMPRESSION DEVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 115
TABLE 63 NORTH AMERICA: PNEUMATIC COMPRESSION DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 116
TABLE 64 EUROPE: PNEUMATIC COMPRESSION DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 116
TABLE 65 ASIA PACIFIC: PNEUMATIC COMPRESSION DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 117
TABLE 66 LATIN AMERICA: PNEUMATIC COMPRESSION DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 117
TABLE 67 MIDDLE EAST & AFRICA: PNEUMATIC COMPRESSION DEVICES MARKET,
BY REGION, 2023–2030 (USD MILLION) 118
TABLE 68 PNEUMATIC COMPRESSION DEVICES MARKET, BY TECHNIQUE,
2023–2030 (USD MILLION) 118
TABLE 69 PNEUMATIC COMPRESSION DEVICES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 119
TABLE 70 PNEUMATIC COMPRESSION DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION) 119
TABLE 71 INTERMITTENT COMPRESSION DEVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 120
TABLE 72 SEQUENTIAL COMPRESSION DEVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 121
TABLE 73 COMPRESSION BRACES MARKET, BY REGION, 2023–2030 (USD MILLION) 122
TABLE 74 NORTH AMERICA: COMPRESSION BRACES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 122
TABLE 75 EUROPE: COMPRESSION BRACES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 123
TABLE 76 ASIA PACIFIC:COMPRESSION BRACES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 123
TABLE 77 LATIN AMERICA: COMPRESSION BRACES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 124
TABLE 78 MIDDLE EAST & AFRICA: COMPRESSION BRACES, BY REGION,
2023–2030 (USD MILLION) 124
TABLE 79 COMPRESSION BRACES MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 124
TABLE 80 COMPRESSION BRACES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 125
TABLE 81 COMPRESSION BRACES MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 125
TABLE 82 OTHER COMPRESSION GARMENTS MARKET, BY REGION,
2023–2030 (USD MILLION) 126
TABLE 83 NORTH AMERICA: OTHER COMPRESSION GARMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 126
TABLE 84 EUROPE: OTHER COMPRESSION GARMENTS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 127
TABLE 85 ASIA PACIFIC: OTHER COMPRESSION GARMENTS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 127
TABLE 86 LATIN AMERICA: OTHER COMPRESSION GARMENTS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 128
TABLE 87 MIDDLE EAST & AFRICA: OTHER COMPRESSION GARMENTS MARKET, BY REGION, 2023–2030 (USD MILLION) 128
TABLE 88 OTHER COMPRESSION GARMENTS MARKET, BY TECHNIQUE,
2023–2030 (USD MILLION) 128
TABLE 89 OTHER COMPRESSION GARMENTS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 129
TABLE 90 OTHER COMPRESSION GARMENTS MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 129
TABLE 91 COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 131
TABLE 92 STATIC COMPRESSION THERAPY MARKET, BY REGION,
2023–2030 (USD MILLION) 132
TABLE 93 DYNAMIC COMPRESSION THERAPY MARKET, BY REGION,
2023–2030 (USD MILLION) 133
TABLE 94 COMPRESSION THERAPY MARKET, BY APPLICATION, 2023–2030(USD MILLION) 135
TABLE 95 COMPRESSION THERAPY MARKET FOR VARICOSE VEIN TREATMENT, BY REGION, 2023–2030 (USD MILLION) 136
TABLE 96 COMPRESSION THERAPY MARKET FOR DEEP VEIN THROMBOSIS TREATMENT,
BY REGION, 2023–2030 (USD MILLION) 137
TABLE 97 COMPRESSION THERAPY MARKET FOR LYMPHEDEMA TREATMENT, BY REGION, 2023–2030 (USD MILLION) 138
TABLE 98 COMPRESSION THERAPY MARKET FOR LEG ULCER TREATMENT, BY REGION, 2023–2030 (USD MILLION) 139
TABLE 99 COMPRESSION THERAPY MARKET FOR OTHER APPLICATIONS, BY REGION,
2023–2030 (USD MILLION) 140
TABLE 100 COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 142
TABLE 101 COMPRESSION THERAPY MARKET FOR PHARMACIES & RETAILERS, BY REGION, 2023–2030 (USD MILLION) 143
TABLE 102 COMPRESSION THERAPY MARKET FOR E-COMMERCE PLATFORMS, BY REGION, 2023–2030 (USD MILLION) 144
TABLE 103 COMPRESSION THERAPY MARKET FOR HOSPITALS & CLINICS, BY REGION,
2023–2030 (USD MILLION) 145
TABLE 104 COMPRESSION THERAPY MARKET FOR HOME CARE SETTINGS, BY REGION,
2023–2030 (USD MILLION) 146
TABLE 105 COMPRESSION THERAPY MARKET, BY REGION, 2023–2030 (USD MILLION) 148
TABLE 106 NORTH AMERICA: MACROECONOMIC INDICATORS 149
TABLE 107 NORTH AMERICA: COMPRESSION THERAPY MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 151
TABLE 108 NORTH AMERICA: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 151
TABLE 109 NORTH AMERICA: COMPRESSION THERAPY MARKET, BY TECHNIQUE,
2023–2030 (USD MILLION) 152
TABLE 110 NORTH AMERICA: COMPRESSION THERAPY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 152
TABLE 111 NORTH AMERICA: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION) 153
TABLE 112 US: KEY MACROINDICATORS 154
TABLE 113 US: COMPRESSION THERAPY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 154
TABLE 114 CANADA: KEY MACROINDICATORS 155
TABLE 115 CANADA: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 156
TABLE 116 EUROPE: MACROECONOMIC INDICATORS 157
TABLE 117 EUROPE: COMPRESSION THERAPY MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 158
TABLE 118 EUROPE: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 158
TABLE 119 EUROPE: COMPRESSION THERAPY MARKET, BY TECHNIQUE,
2023–2030 (USD MILLION) 159
TABLE 120 EUROPE: COMPRESSION THERAPY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 159
TABLE 121 EUROPE: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 160
TABLE 122 GERMANY: KEY MACROINDICATORS 161
TABLE 123 GERMANY: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 161
TABLE 124 FRANCE: KEY MACROINDICATORS 162
TABLE 125 FRANCE: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 163
TABLE 126 UK: KEY MACROINDICATORS 164
TABLE 127 UK: COMPRESSION THERAPY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 164
TABLE 128 ITALY: KEY MACROINDICATORS 165
TABLE 129 ITALY: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 166
TABLE 130 SPAIN: KEY MACROINDICATORS 167
TABLE 131 SPAIN: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 167
TABLE 132 HIP SURGERY PROCEDURES (TOTAL PATIENTS) IN EUROPEAN COUNTRIES 168
TABLE 133 REST OF EUROPE: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 168
TABLE 134 ASIA PACIFIC: MACROECONOMIC INDICATORS 170
TABLE 135 ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 172
TABLE 136 ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 172
TABLE 137 ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY TECHNIQUE,
2023–2030 (USD MILLION) 173
TABLE 138 ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 173
TABLE 139 ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION) 174
TABLE 140 CHINA: KEY MACROINDICATORS 175
TABLE 141 CHINA: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 175
TABLE 142 JAPAN: KEY MACROINDICATORS 176
TABLE 143 JAPAN: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 177
TABLE 144 INDIA: KEY MACROINDICATORS 178
TABLE 145 INDIA: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 178
TABLE 146 AUSTRALIA: KEY MACROINDICATORS 179
TABLE 147 AUSTRALIA: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 180
TABLE 148 SOUTH KOREA: KEY MACROINDICATORS 181
TABLE 149 SOUTH KOREA: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 181
TABLE 150 REST OF ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 182
TABLE 151 LATIN AMERICA: MACROECONOMIC INDICATORS 183
TABLE 152 LATIN AMERICA: COMPRESSION THERAPY MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 184
TABLE 153 LATIN AMERICA: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 184
TABLE 154 LATIN AMERICA: COMPRESSION THERAPY MARKET, BY TECHNIQUE,
2023–2030 (USD MILLION) 185
TABLE 155 LATIN AMERICA: COMPRESSION THERAPY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 185
TABLE 156 LATIN AMERICA: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION) 186
TABLE 157 BRAZIL: KEY MACROINDICATORS 187
TABLE 158 BRAZIL: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 187
TABLE 159 MEXICO: KEY MACROINDICATORS 188
TABLE 160 MEXICO: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 189
TABLE 161 REST OF LATIN AMERICA: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 190
TABLE 162 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 191
TABLE 163 MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET, BY REGION,
2023–2030 (USD MILLION) 191
TABLE 164 MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 192
TABLE 165 MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 192
TABLE 166 MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 193
TABLE 167 MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET,
BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION) 193
TABLE 168 GCC COUNTRIES: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 194
TABLE 169 REST OF MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 195
TABLE 170 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN
COMPRESSION THERAPY MARKET 197
TABLE 171 COMPRESSION THERAPY MARKET: DEGREE OF COMPETITION 202
TABLE 172 COMPRESSION THERAPY MARKET: REGION FOOTPRINT 206
TABLE 173 COMPRESSION THERAPY MARKET: PRODUCT FOOTPRINT 206
TABLE 174 COMPRESSION THERAPY MARKET: APPLICATION FOOTPRINT 207
TABLE 175 COMPRESSION THERAPY MARKET: TECHNIQUE FOOTPRINT 208
TABLE 176 COMPRESSION THERAPY MARKET: DISTRIBUTION CHANNEL FOOTPRINT 209
TABLE 177 LIST OF KEY START-UPS/SMES 212
TABLE 178 COMPETITIVE BENCHMARKING OF START-UPS/SMES 213
TABLE 179 COMPRESSION THERAPY MARKET: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021–APRIL 2025 216
TABLE 180 COMPRESSION THERAPY MARKET: DEALS, JANUARY 2021–APRIL 2025 217
TABLE 181 SOLVENTUM CORPORATION: COMPANY OVERVIEW 219
TABLE 182 SOLVENTUM CORPORATION (3M): PRODUCTS OFFERED 220
TABLE 183 SOLVENTUM CORPORATION (3M): PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021–APRIL 2025 222
TABLE 184 SOLVENTUM CORPORATION (3M): DEALS, JANUARY 2021–APRIL 2025 222
TABLE 185 ENOVIS CORPORATION: COMPANY OVERVIEW 224
TABLE 186 ENOVIS CORPORATION: PRODUCTS OFFERED 225
TABLE 187 ENOVIS CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025 226
TABLE 188 ENOVIS CORPORATION: DEALS, JANUARY 2021–APRIL 2025 226
TABLE 189 ESSITY: COMPANY OVERVIEW 228
TABLE 190 ESSITY: PRODUCTS OFFERED 229
TABLE 191 ESSITY: DEALS, JANUARY 2021–APRIL 2025 230
TABLE 192 CARDINAL HEALTH: COMPANY OVERVIEW 232
TABLE 193 CARDINAL HEALTH: PRODUCTS OFFERED 233
TABLE 194 CARDINAL HEALTH: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021–APRIL 2025 234
TABLE 195 ARJOHUNTLEIGH: COMPANY OVERVIEW 236
TABLE 196 ARJOHUNTLEIGH: PRODUCTS OFFERED 237
TABLE 197 TACTILE MEDICAL: COMPANY OVERVIEW 239
TABLE 198 TACTILE MEDICAL: PRODUCTS OFFERED 240
TABLE 199 TACTILE MEDICAL: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025 240
TABLE 200 CONVATEC INC.: COMPANY OVERVIEW 241
TABLE 201 CONVATEC INC.: PRODUCTS OFFERED 242
TABLE 202 CONVATEC INC.: DEALS, JANUARY 2021–APRIL 2025 243
TABLE 203 BIO COMPRESSION SYSTEMS, INC.: COMPANY OVERVIEW 244
TABLE 204 BIO COMPRESSION SYSTEMS, INC.: PRODUCTS OFFERED 244
TABLE 205 JUZO GMBH: COMPANY OVERVIEW 245
TABLE 206 JUZO GMBH: PRODUCTS OFFERED 245
TABLE 207 JUZO GMBH: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025 246
TABLE 208 MEDI GMBH & CO. KG: COMPANY OVERVIEW 247
TABLE 209 MEDI GMBH & CO. KG: PRODUCTS OFFERED 247
TABLE 210 PAUL HARTMANN: COMPANY OVERVIEW 249
TABLE 211 PAUL HARTMANN: PRODUCTS OFFERED 250
TABLE 212 PAUL HARTMANN: DEALS, JANUARY 2021–APRIL 2025 251
TABLE 213 SANYLEG, S.R.L.: COMPANY OVERVIEW 252
TABLE 214 SANYLEG, S.R.L.: PRODUCTS OFFERED 252
TABLE 215 SIGVARIS GROUP: COMPANY OVERVIEW 254
TABLE 216 SIGVARIS GROUP: PRODUCTS OFFERED 254
TABLE 217 SIGVARIS GROUP.: DEALS, JANUARY 2021–APRIL 2025 255
TABLE 218 SMITH+NEPHEW: COMPANY OVERVIEW 256
TABLE 219 SMITH+NEPHEW: PRODUCTS OFFERED 257
TABLE 220 SMITH+NEPHEW: EXPANSIONS, JANUARY 2021–APRIL 2025 258
TABLE 221 MEGO AFEK, LTD.: COMPANY OVERVIEW 259
TABLE 222 MEGO AFEK, LTD.: PRODUCTS OFFERED 259
TABLE 223 GOTTFRIED MEDICAL, INC.: COMPANY OVERVIEW 261
TABLE 224 THERMOTEK, INC.: COMPANY OVERVIEW 262
TABLE 225 BAUERFEIND AG: COMPANY OVERVIEW 263
TABLE 226 OFA BAMBERG GMBH: COMPANY OVERVIEW 264
TABLE 227 MEDLINE INDUSTRIES: COMPANY OVERVIEW 265
TABLE 228 ACI MEDICAL: COMPANY OVERVIEW 266
TABLE 229 AIROS MEDICAL INC.: COMPANY OVERVIEW 267
TABLE 230 BARCELCOM TÊXTEIS, S.A: COMPANY OVERVIEW 268
TABLE 231 CIZETA MEDICALI S.P.A: COMPANY OVERVIEW 269
TABLE 232 BÖSL MEDIZINTECHNIK: COMPANY OVERVIEW 270
FIGURE 1 COMPRESSION THERAPY MARKET SEGMENTATION & REGIONAL SCOPE 26
FIGURE 2 COMPRESSION THERAPY MARKET: RESEARCH DATA 30
FIGURE 3 COMPRESSION THERAPY MARKET: RESEARCH DESIGN 31
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 36
FIGURE 5 MARKET SIZE ESTIMATION: COMPANY REVENUE ESTIMATION 37
FIGURE 6 COMPRESSION THERAPY MARKET: MARKET SIZE ESTIMATION METHODOLOGY 38
FIGURE 7 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 39
FIGURE 8 GROWTH PROJECTIONS ON REVENUE IMPACT OF KEY MACROINDICATORS 41
FIGURE 9 DATA TRIANGULATION 42
FIGURE 10 COMPRESSION THERAPY MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 44
FIGURE 11 COMPRESSION THERAPY MARKET, BY APPLICATION,
2025 VS. 2030 (USD MILLION) 45
FIGURE 12 COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2025 VS. 2030 (USD MILLION) 46
FIGURE 13 COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL,
2025 VS. 2030 (USD MILLION) 46
FIGURE 14 COMPRESSION THERAPY MARKET: GEOGRAPHIC OUTLOOK 47
FIGURE 15 GROWING INCIDENCE OF SPORTS INJURIES AND FAVORABLE CLINICAL EVIDENCE TO DRIVE MARKET GROWTH 48
FIGURE 16 ASIA PACIFIC TO BE FASTEST-GROWING MARKET FOR COMPRESSION
THERAPY DURING FORECAST PERIOD 49
FIGURE 17 HOSPITALS & CLINICS AND US WERE LARGEST SEGMENTS IN 2024 50
FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 51
FIGURE 19 COMPRESSION THERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 52
FIGURE 20 GERIATRIC POPULATION, BY REGION, 2015 VS. 2030 VS. 2050 53
FIGURE 21 EUROPE: ROAD DEATHS PER MILLION INHABITANTS, BY COUNTRY, 2021 54
FIGURE 22 REASONS FOR NON-COMPLIANCE WITH COMPRESSION THERAPY 57
FIGURE 23 PORTER’S FIVE FORCES ANALYSIS 60
FIGURE 24 COMPRESSION THERAPY MARKET: ECOSYSTEM ANALYSIS 67
FIGURE 25 COMPRESSION THERAPY MARKET: INVESTMENT & FUNDING SCENARIO,
2019–2023 (USD MILLION) 68
FIGURE 26 NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 68
FIGURE 27 VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 (USD MILLION) 69
FIGURE 28 COMPRESSION THERAPY MARKET: VALUE CHAIN ANALYSIS 72
FIGURE 29 COMPRESSION THERAPY MARKET: SUPPLY CHAIN ANALYSIS 73
FIGURE 30 AVERAGE SELLING PRICE TREND OF COMPRESSION THERAPY PRODUCTS,
BY TYPE, 2022–2024 (USD THOUSAND) 74
FIGURE 31 AVERAGE SELLING PRICE TREND OF COMPRESSION THERAPY MARKET,
BY PRODUCT TYPE, 2022–2024 (USD) 75
FIGURE 32 AVERAGE SELLING PRICE TREND OF COMPRESSION STOCKINGS, BY KEY PLAYER, 2022–2024 (USD THOUSAND) 75
FIGURE 33 AVERAGE SELLING PRICE TREND OF COMPRESSION BRACES, BY KEY PLAYER, 2022–2024 (USD THOUSAND) 76
FIGURE 34 AVERAGE SELLING PRICE TREND OF COMPRESSION THERAPY PRODUCTS,
BY REGION, 2022–2024 (USD THOUSAND) 77
FIGURE 35 COMPRESSION THERAPY MARKET: PATENT ANALYSIS 79
FIGURE 36 COMPRESSION THERAPY MARKET: IMPORT SCENARIO FOR HS CODE 611510, 2020–2024 80
FIGURE 37 COMPRESSION THERAPY MARKET: EXPORT SCENARIO FOR HS CODE 611510, 2020–2024 81
FIGURE 38 TRENDS & DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 83
FIGURE 39 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF COMPRESSION
THERAPY PRODUCTS 84
FIGURE 40 KEY BUYING CRITERIA FOR TOP THREE END USERS 85
FIGURE 41 NORTH AMERICA: COMPRESSION THERAPY MARKET SNAPSHOT 150
FIGURE 42 ASIA PACIFIC: COMPRESSION THERAPY MARKET SNAPSHOT 171
FIGURE 43 REVENUE ANALYSIS OF TOP FIVE PLAYERS IN COMPRESSION THERAPY MARKET, 2020–2024 199
FIGURE 44 COMPRESSION STOCKINGS MARKET SHARE ANALYSIS, 2024 200
FIGURE 45 COMPRESSION BANDAGES MARKET SHARE ANALYSIS, 2024 200
FIGURE 46 PNEUMATIC COMPRESSION DEVICES MARKET SHARE ANALYSIS, 2024 201
FIGURE 47 COMPRESSION THERAPY MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2024 204
FIGURE 48 COMPRESSION THERAPY MARKET: COMPANY FOOTPRINT 205
FIGURE 49 COMPRESSION THERAPY MARKET: COMPANY EVALUATION MATRIX
(START-UPS/SMES), 2024 211
FIGURE 50 EV/EBITDA OF KEY VENDORS 214
FIGURE 51 5-YEAR STOCK BETA OF KEY VENDORS 214
FIGURE 52 BRAND/PRODUCT COMPARATIVE ANALYSIS 215
FIGURE 53 SOLVENTUM CORPORATION: COMPANY SNAPSHOT (2024) 220
FIGURE 54 ENOVIS CORPORATION: COMPANY SNAPSHOT (2024) 225
FIGURE 55 ESSITY: COMPANY SNAPSHOT (2024) 229
FIGURE 56 CARDINAL HEALTH: COMPANY SNAPSHOT (2024) 233
FIGURE 57 ARJOHUNTLEIGH: COMPANY SNAPSHOT (2024) 237
FIGURE 58 TACTILE MEDICAL: COMPANY SNAPSHOT (2024) 239
FIGURE 59 CONVATEC INC.: COMPANY SNAPSHOT (2024) 242
FIGURE 60 PAUL HARTMANN: COMPANY SNAPSHOT (2024) 250
FIGURE 61 SMITH+NEPHEW: COMPANY SNAPSHOT (2024) 257